PERISCOPE CAPITAL INC. - BIOPLUS ACQUISITION CORP ownership

BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217125. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PERISCOPE CAPITAL INC. ownership history of BIOPLUS ACQUISITION CORP
ValueSharesWeighting
Q3 2023$48,556
-60.3%
867,0720.0%0.01%
-44.4%
Q2 2023$122,173
+62.0%
867,0720.0%0.01%
+200.0%
Q1 2023$75,417
+103.1%
867,0720.0%0.00%
+50.0%
Q4 2022$37,140
-61.7%
867,072
+17.9%
0.00%
-33.3%
Q3 2022$97,000
+470.6%
735,572
+488.9%
0.00%
Q2 2022$17,000
-41.4%
124,9000.0%0.00%
-100.0%
Q1 2022$29,000124,9000.00%
Other shareholders
BIOPLUS ACQUISITION CORP shareholders Q2 2022
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 369,289$3,774,1340.21%
Radcliffe Capital Management, L.P. 200,049$2,052,5030.06%
LMR Partners LLP 125,000$1,277,5000.02%
Q Global Advisors, LLC 195,489$200.01%
MARSHALL WACE, LLP 190,150$1,954,7430.00%
MMCAP International Inc. SPC 325,000$32,4680.00%
PERISCOPE CAPITAL INC. 867,072$37,1400.00%
COWEN AND COMPANY, LLC 177,845$17,7660.00%
CANTOR FITZGERALD, L. P. 250,000$250.00%
EHP Funds Inc. 125,186$60.00%
View complete list of BIOPLUS ACQUISITION CORP shareholders